More
    Guided Solutions - Connecting Talent With Innovation/div>

    GS MedTech Funding Tracker – Distalmotion, Okami and more

    This week in MedTech, major acquisitions and targeted investments are reshaping the competitive landscape. Abbott’s $21B move for Exact Sciences, GE HealthCare’s push into AI-driven imaging with Intelerad's acquisition, and Solventum’s expansion into soft...

    GS MedTech Funding Tracker – Distalmotion, Okami and more

    This week in MedTech, major acquisitions and targeted investments are reshaping the competitive landscape. Abbott’s $21B move for Exact Sciences, GE HealthCare’s push into...

    GE HealthCare to advance enterprise imaging through Intelerad acquisition

    GE HealthCare announced it agreed to acquire Intelerad, a medical imaging software provider, for $2.3 billion. Chicago-based GE HealthCare plans to complete the deal in...

    Okami secures $45m to advance clinical programmes for vascular disease

    Okami Medical has closed a financing round, raising $45m, to expand its commercial presence and progress clinical programmes focused on improving outcomes for vascular...

    Neurolyser XR now FDA cleared for sale in USA

    FUSMobile announced that it received De Novo marketing authorization (DEN250015) from the FDA to begin marketing and sales of the Neurolyser XR system for...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    Vexev robotic ultrasound study meets endpoints

    Vexev and U.S. Renal Care announced successful results from the CANSCAN trial of the VxWave robotic ultrasound imaging system. Sydney, Australia-based Vexev develops the...

    Hyperion completes first-in-human study of Ivy robotic vascular access platform

    Hyperion Surgical announced today that it completed the world’s first robotic-assisted intravenous (IV) catheterisation using its Ivy platform. Ivy integrates advanced imaging, AI and robotic...

    AtriCure treats first patient in the BoxX-NoAF clinical trial

    AtriCure, a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced...

    Penumbra study backs Lightning Flash 2.0 mechanical thrombectomy system

    Penumbra announced positive results from its landmark STORM-PE randomised controlled trial. The study found that the use of the company’s computer-assisted vacuum thrombectomy (CAVT) system,...

    Innovation

    Regulatory Approvals

    GS MedTech Funding Tracker – Distalmotion, Okami and more

    This week in MedTech, major acquisitions and targeted investments are reshaping the competitive landscape. Abbott’s $21B move for Exact Sciences, GE HealthCare’s push into...

    GE HealthCare to advance enterprise imaging through Intelerad acquisition

    GE HealthCare announced it agreed to acquire Intelerad, a medical imaging software provider, for $2.3 billion. Chicago-based GE HealthCare plans to complete the deal in...

    Okami secures $45m to advance clinical programmes for vascular disease

    Okami Medical has closed a financing round, raising $45m, to expand its commercial presence and progress clinical programmes focused on improving outcomes for vascular...

    Neurolyser XR now FDA cleared for sale in USA

    FUSMobile announced that it received De Novo marketing authorization (DEN250015) from the FDA to begin marketing and sales of the Neurolyser XR system for...

    M&A

    Archives

    Latest articles